Table 4.
Pathways Linked to a ≥10-Point Gain in BP Outcome
| Pathway | Consistency, % (No./N) | Raw Coverage, % (No./N) | Unique Coverage, % (No./N) | Cases Included in Pathwaya |
|---|---|---|---|---|
| Take second BP = 1 AND Documentation = 1 AND Ownership = clinician |
91 (10/11) | 38 (10/26) | 19 (5/26) | A2, A3, A6, B8, C3, C4, E2, E3, F3, G2 |
| Take second BP = 1 AND Duration of facilitation = ≥50 hours |
100 (3/3) | 12 (3/26) | 4 (2/26) | A1, B8, B9 |
| Measurement training = 2 AND Duration of facilitation = 10-24.9 hours |
75 (3/4) | 12 (3/26) | 4 (2/26) | E2, G4, G5 |
| Measurement training = 1 (ie, without follow-up) AND Size = solo clinician |
73 (8/11) | 31 (8/26) | 15 (4/26) | A2, A3, A6, A7, B8, F1, F4, F5 |
| Overall model | 82 (18/22) | 69 (18/26) | N/A |
BP = blood pressure; N/A = not applicable.
a
Bold indicates cases uniquely explained by each pathway. Each letter refers to a different Cooperative and each number to a different practice in that Cooperative.